Clinical Trial Site

Kansas City, Missouri 66103

5 studies enrolling now · 9 studies all time

What they study most

Angelman Syndrome, Breast Cancer, ER Positive Breast Cancer, HER2 Negative Breast Carcinoma, Hereditary Transthyretin-mediated (ATTRv) Amyloidosis, High Cardiovascular Risk, High Risk Cardiovascular Disease, Hypertension, Hypophosphatasia, Iron Deficiency Anemia, Lichen Planopilaris, Locally Advanced Breast Cancer

Studies at this site

• A Safety and Efficacy Study of GTX-102 in Subjects With Deletion- or Nondeletion-type Angelman Syndrome (AS) — Recruiting now
• Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer — Recruiting now
• Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease — Recruiting now
• A Phase 2/3 Study of Brepocitinib in Adults With Lichen Planopilaris — Recruiting now
• A Prospective Sub-Study of the Global Hypophosphatasia Registry — Recruiting now
• A Phase III Safety Study of Ferumoxytol Compared to Ferric Carboxymaltose for the Treatment of Iron Deficiency Anemia (IDA) — Completed
• A Multicenter Observational Study to Evaluate the Effectiveness of Patisiran in Patients With Polyneuropathy of ATTRv Amyloidosis With a V122I or T60A Mutation — Completed
• A Trial Comparing Ferumoxytol With Placebo for the Treatment of Iron Deficiency Anemia — Completed
• A Trial of Ferumoxytol for the Episodic Treatment of Iron Deficiency Anemia — Completed